Zusammenfassung
Kopfschmerzen gehören zu den am häufigsten beklagten Beschwerden und Symptomen in der ärztlichen Praxis. In den letzten 100 Jahren hat sich ein dramatischer Wissenszuwachs in den Bereichen Epidemiologie, Pathophysiologie, Akuttherapie und präventiver Therapie ergeben. Der Durchbruch in der Akutbehandlung von Migräneattacken kam mit der Einführung der Triptane. Für die medikamentöse Migräneprophylaxe stehen β-Rezeptoren-Blocker, Kalziumantagonisten und Neuromodulatoren zur Verfügung. Unbefriedigend ist immer noch die Behandlung des chronischen Spannungskopfschmerzes. Der Clusterkopfschmerz wird in der Gruppe der trigeminoautonomen Kopfschmerzen subsumiert. Eine zunehmend wichtige Rolle spielt der medikamenteninduzierte Dauerkopfschmerz. Neue Versorgungsstrukturen wie die integrierte Versorgung Kopfschmerz sorgen für eine bessere Betreuung von Patienten mit chronischen Kopfschmerzen.
Summary
Headaches are one of the most common disorders and symptoms in daily medical practice. There has been dramatic progress of knowledge in the fields of epidemiology, pathophysiology, acute treatment, and preventive therapy over the past 100 years. Triptans have been the breakthrough in the treatment of acute migraine attacks. Beta blockers, calcium antagonists, and neuromodulators are available for preventive migraine therapy. Treatment for chronic tension headache is still unsatisfying. Cluster headache is part of the group of trigemino-autonomic headaches. Headache from medication overuse plays an increasingly important role. New medical care structures such as integrated headache care provide better support for patients with chronic headache disorders.
Literatur
Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia [Suppl 7] 8: 1–93
Olesen J, Bousser M-G, Diener H et al. (2004) The International Classification of Headache Disorders. 2nd edn. Cephalalgia [Suppl 1] 24: 1–160
Schwartz BS, Stewart WF, Simon D, Lipton RB (1998) Epidemiology of tension-type headache. JAMA 279: 381–383
Silberstein SD, Lipton RB (1993) Epidemiology of migraine. Neuroepidemiology 12: 179–194
Kavuk IYA, Cetindere U, Agelink MW, Diener HC (2003) Epidemiology of chronic daily headache. Eur J Med Res 8: 236–240
Lanteri-Minet M, Radat F, Chautard MH, Lucas C (2005) Anxiety and depression associated with migraine: influence on migraine subjects‘ disability and quality of life, and acute migraine management. Pain 118: 319–326
Radat F, Swendsen J (2005) Psychiatric comorbidity in migraine: a review. Cephalalgia 25: 165–178
Oedegaard KJ, Neckelmann D, Mykletun A et al. (2006) Migraine with and without aura: association with depression and anxiety disorder in a population-based study. The HUNT Study. Cephalalgia 26: 1–6
Scher AI, Bigal ME, Lipton RB (2005) Comorbidity of migraine. Curr Opin Neurol 18: 305–310
Kurth T, Holtmann G, Neufang-Huber J et al. (2006) Prevalence of unexplained upper abdominal symptoms in patients with migraine. Cephalalgia 26: 506–510
Bigal ME, Lipton RB (2006) Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 67: 252–257
Diener HC, Kurth T, Dodick D (2007) Patent foramen ovale, stroke, and cardiovascular disease in migraine. Curr Opin Neurol 20: 310–319
Kurth T, Slomke MA, Kase CS et al. (2005) Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 64: 1020–1026
Kurth T, Gaziano JM, Cook NR et al. (2006) Migraine and risk of cardiovascular disease in women. JAMA 296: 283–291
Kurth T, Gaziano JM, Cook NR et al. (2007) Migraine and risk of cardiovascular disease in men. Arch Intern Med 167: 795–801
Scher A, Terwindt G, Picavet H et al. (2005) Cardiovascular risk factors and migraine: The GEM population-based study. Neurology 64: 614–620
Diener HC, Kurth T, Dodick D (2007) Patent foramen ovale and migraine. Curr Pain Headache Rep 11: 236–240
Hadjikhani N, Sanchez del Rio M, Wu O et al. (2001) Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 98: 4687–4692
Sanchez del Rio M, Bakker D, Wu O et al. (1999) Perfusion weighted imaging during migraine: spontaneous visual aura and headache. Cephalalgia 19: 701–707
Kirchmann M, Thomsen LL, Olesen J (2006) Basilar-type migraine: clinical, epidemiologic, and genetic features. Neurology 66: 880–886
Neuhauser HK, Radtke A, Brevern M von et al. (2006) Migrainous vertigo: prevalence and impact on quality of life. Neurology 67: 1028–1033
Creutzig A, Alexander K (1985) Ergotismus. Dtsch Med Wochenschr 110: 1420–1422
Zschiedrich M, Heidrich H, Dienes HP (1985) Ergotismus: Epidemiologie, Pathogenese, Histomorphologie, Diagnostik und Therapie. Med Klinik 80: 721–727
Füeßel H (1987) Chronischer Ergotismus. Selecta 33: 20063
Humphrey PPA, Feniuk W, Perren M et al. (1989) Sumatriptan succinate. Drugs Future 14: 35–39
Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358: 1668–1675
Fox AW, Chambers CD, Anderson PO et al. (2002) Evidence-based assessment of pregnancy outcome after sumatriptan exposure. Headache 42: 8–15
Fiore M, Shields KE, Santanello N, Goldberg MR (2005) Exposure to rizatriptan during pregnancy: post-marketing experience up to 30 June 2004. Cephalalgia 25: 685–688
Diener H, Pfaffenrath V, Pageler L et al. (2005) The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multi-centre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 25: 776–778
Goldstein J, Silberstein SD, Saper JR et al. (2006) Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study. Headache 46: 444–453
Leinisch E, Evers S, Kaempfe N et al. (2005) Evaluation of the efficacy of intravenous acetaminophen in the treatment of acute migraine attacks: a double-blind, placebo-controlled parallel group multicenter study. Pain 117: 396–400
Diener H, Limmroth V, Fritsche G et al. (2005) Therapie der Migräneattacke und Migräneprophylaxe. Leitlinie der Deutschen Gesellschaft für Neurologie und der Deutschen Migräne- und Kopfschmerzgesellschaft. In: Diener H, für die Kommission Leitlinien der DGN (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie. 3. Aufl. Thieme, Stuttgart
Bussone G, Diener H, Pfeil J, Schwalen S (2005) Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Int J Clin Pract 59: 961–968
Silberstein SD, Lipton RB, Dodick DW et al. (2007) Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 47: 170–180
Silvestrini M, Bartolini M, Coccia M et al. (2003) Topiramate in the treatment of chronic migraine. Cephalalgia 23: 820–824
Diener H, Bussone G, Van Oene J et al. (2007) Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebo-controlled study. Cephalalgia 27(7): 814–823
Ayata C, Jin H, Kudo C et al. (2006) Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 59: 652–661
Linde K, Streng A, Jurgens S et al. (2005) Acupuncture for patients with migraine: a randomized controlled trial. JAMA 293: 2118–2125
Diener HC, Kronfeld K, Boewing G et al. (2006) Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol 5: 310–316
MacGregor EA, Frith A, Ellis J et al. (2006) Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 67: 2159–2163
Ashina S, Bendtsen L, Ashina M et al. (2006) Generalized hyperalgesia in patients with chronic tension-type headache. Cephalalgia 26: 940–948
Russell MB, Saltyte-Benth J, Levi N (2006) Are infrequent episodic, frequent episodic and chronic tension-type headache inherited? A population-based study of 11 199 twin pairs. J Headache Pain 7: 119–126
Schmidt-Wilcke T, Leinisch E, Straube A et al. (2005) Gray matter decrease in patients with chronic tension type headache. Neurology 65: 1483–1486
Zissis NP, Harmoussi S, Vlaikidis N et al. (2007) A randomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache. Cephalalgia 27: 315–324
Lampl C, Marecek S, May A, Bendtsen L (2006) A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache. Cephalalgia 26: 1203–1208
Silberstein SD, Gobel H, Jensen R et al. (2006) Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study. Cephalalgia 26: 790–800
Mathew NT, Frishberg BM, Gawel M et al. (2005) Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache 45: 293–307
Horton BT, Peters GA (1963) Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases. Headache 3: 214–226
Peters GA, Horton BT (1951) Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proceed Staff Meet Mayo Clin 26: 153–161
Dichgans J, Diener HC, Gerber WD et al. (1984) Analgetika-induzierter Dauerkopfschmerz. Dtsch Med Wochenschr 109: 369–373
Diener HC, Limmroth V (2004) Medication-overuse headache: a worldwide problem. Lancet Neurol 3: 475–483
Limmroth V, Katsarava Z, Fritsche G et al. (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59: 1011–1014
Paemeleire K, Bahra A, Evers S et al. (2006) Medication-overuse headache in patients with cluster headache. Neurology 67: 109–113
Cittadini E, May A, Straube A et al. (2006) Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. Arch Neurol 63: 1537–1542
Leone M, Franzini A, D’Amico D et al. (2001) Stereotactic electrode implant in inferior posterior hypothalamic gray matter to relieve intractable chronic cluster headache: the first reported case. Neurology [Suppl 3] 56: A218
Leone M, Franzini A, Broggi G, Bussone G (2003) Hypothalamic deep brain stimulation for intractable chronic cluster headache: a 3-year follow up. J Neurol Sci [Suppl 2] 24: 143–145
Schoenen J, Di Clemente L, Vandenheede M et al. (2005) Hypothalamic stimulation in chronic cluster headache: a pilot study of efficacy and mode of action. Brain 128: 940–947
Magis D, Allena M, Bolla M et al. (2007) Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study. Lancet Neurol 6: 314–321
Schwedt TJ, Dodick DW, Hentz J et al. (2007) Occipital nerve stimulation for chronic headache – long-term safety and efficacy. Cephalalgia 27: 153–157
Burns B, Watkins L, Goadsby PJ (2007) Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients. Lancet 369: 1099–1106
Chang YJ, Ryu SJ, Lee TH (2006) Dose titration to reduce dipyridamole-related headache. Cerebrovasc Dis 22: 258–262
Olesen J, Diener H, Husstedt IW et al. (2004) Calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS is effective in the treatment of migraine attacks. N Engl J Med 350: 1104–1110
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Anhang
Anhang
Rights and permissions
About this article
Cite this article
Diener, H., Slomke, M. & Limmroth, V. Kopfschmerzen und Migräne. Nervenarzt 78 (Suppl 1), 7–14 (2007). https://doi.org/10.1007/s00115-007-2332-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00115-007-2332-y
Schlüsselwörter
- Kopfschmerzen
- Epidemiologie
- Migräne
- Spannungskopfschmerz
- Clusterkopfschmerz
- Medikamenteninduzierter Dauerkopfschmerz